Optimizing Induction Chemotherapy Regimens for ND Elderly AML Patients Who Are Eligible for Intense Chemotherapy

NCT06066242 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
113
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institute of Hematology & Blood Diseases Hospital, China